Focused Wealth Management’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-112
| Closed | -$9K | – | 1087 |
|
|
2022
Q1 | $9K | Hold |
112
| – | – | ﹤0.01% | 569 |
|
|
2021
Q4 | $11K | Hold |
112
| – | – | ﹤0.01% | 575 |
|
|
2021
Q3 | $10K | Hold |
112
| – | – | ﹤0.01% | 605 |
|
|
2021
Q2 | $11K | Hold |
112
| – | – | ﹤0.01% | 600 |
|
|
2021
Q1 | $11K | Hold |
112
| – | – | ﹤0.01% | 587 |
|
|
2020
Q4 | $9K | Hold |
112
| – | – | ﹤0.01% | 576 |
|
|
2020
Q3 | $8K | Hold |
112
| – | – | ﹤0.01% | 544 |
|
|
2020
Q2 | $8K | Hold |
112
| – | – | ﹤0.01% | 524 |
|
|
2020
Q1 | $6K | Hold |
112
| – | – | ﹤0.01% | 518 |
|
|
2019
Q4 | $9K | Hold |
112
| – | – | ﹤0.01% | 513 |
|
|
2019
Q3 | $8K | Hold |
112
| – | – | ﹤0.01% | 515 |
|
|
2019
Q2 | $9K | Hold |
112
| – | – | ﹤0.01% | 533 |
|
|
2019
Q1 | $9K | Hold |
112
| – | – | ﹤0.01% | 481 |
|
|
2018
Q4 | $13K | Hold |
112
| – | – | ﹤0.01% | 429 |
|
|
2018
Q3 | $14K | Hold |
112
| – | – | ﹤0.01% | 414 |
|
|
2018
Q2 | $13K | Hold |
112
| – | – | ﹤0.01% | 415 |
|
|
2018
Q1 | $10K | Hold |
112
| – | – | ﹤0.01% | 484 |
|
|
2017
Q4 | $8K | Hold |
112
| – | – | ﹤0.01% | 507 |
|
|
2017
Q3 | $6K | Hold |
112
| – | – | ﹤0.01% | 502 |
|
|
2017
Q2 | $7K | Sell |
112
-2,000
| -95% | -$123K | ﹤0.01% | 525 |
|
|
2017
Q1 | $122K | Hold |
2,112
| – | – | 0.05% | 200 |
|
|
2016
Q4 | $129K | Buy |
2,112
+1,000
| +90% | +$65.2K | 0.05% | 200 |
|
|
2016
Q3 | $77K | Buy |
1,112
+312
| +39% | +$20.6K | 0.03% | 228 |
|
|
2016
Q2 | $45K | Hold |
800
| – | – | 0.02% | 271 |
|
|
2016
Q1 | $49K | Hold |
800
| – | – | 0.03% | 195 |
|
|
2015
Q4 | $51K | Buy |
800
+400
| +100% | +$25.9K | 0.03% | 205 |
|
|
2015
Q3 | $27K | Hold |
400
| – | – | 0.02% | 265 |
|
|
2015
Q2 | $27K | Sell |
400
-200
| -33% | -$12.7K | 0.02% | 276 |
|
|
2015
Q1 | $33K | Hold |
600
| – | – | 0.02% | 252 |
|
|
2014
Q4 | $31K | Sell |
600
-200
| -25% | -$9.82K | 0.02% | 250 |
|
|
2014
Q3 | $29K | Hold |
800
| – | – | 0.02% | 268 |
|
|
2014
Q2 | $31K | Hold |
800
| – | – | 0.02% | 246 |
|
|
2014
Q1 | $30K | Hold |
800
| – | – | 0.03% | 227 |
|
|
2013
Q4 | $30K | Sell |
800
-200
| -20% | -$7.65K | 0.03% | 226 |
|
|
2013
Q3 | $43K | Buy |
+1,000
| New | +$40.1K | 0.04% | 179 |
|
Other funds holding USNA
Focused Wealth Management's USNA Position: Q2 2022 in Review
Focused Wealth Management sold out of Usana Health Sciences (USNA) in Q2 2022, closing a stake of 112 shares — an estimated $9K sold.
Focused Wealth Management first reported a position in USNA in Q3 2013 and held it in 35 quarters. The position peaked at $129K in Q4 2016. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.
- Focused Wealth Management reported no remaining Usana Health Sciences position as of Q2 2022 after selling out during the quarter.
- Focused Wealth Management sold 112 Usana Health Sciences shares in Q2 2022, an estimated $9K.
- Focused Wealth Management first reported a position in Usana Health Sciences in Q3 2013 and held it in 35 quarters.
- Focused Wealth Management's Usana Health Sciences position peaked at $129K in Q4 2016.
- 182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.
Based on Focused Wealth Management's 13F filing for Q2 2022, filed 4 Aug 2022.